泰国医用大麻市场 – 行业趋势及 2031 年预测

泰国医用大麻市场分析和规模

随着研究和创新的不断发展，医用大麻市场在缓解化疗副作用方面也发挥了重要作用。其治疗潜力还延伸到焦虑症、创伤后应激障碍和多发性硬化症。随着合法化和接受度的不断提高，医用大麻有望重新定义传统医学，为全球数百万人带来希望和解脱。                                

Data Bridge Market Research 分析，泰国医用大麻市场在 2023 年为 219.3 亿美元，预计到 2031 年将达到 1320.5 亿美元，预计在 2024 年至 2031 年的预测期内复合年增长率为 25.16%。这表明市场价值。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

市场定义

医用大麻是指在医生的监督下使用大麻及其大麻素治疗症状或疾病。它用于治疗各种疾病，如慢性疼痛、恶心、癫痫和焦虑。它的治疗潜力在于它能够缓解症状并改善符合条件的患者的生活质量。            

泰国医用大麻市场动态

驱动程序

• 慢性病患病率上升带来需求

癌症、多发性硬化症、癫痫和慢性疼痛等慢性疾病的发病率不断上升，这推动了人们对医用大麻等替代疗法的需求。医用大麻具有缓解症状和提高生活质量的潜力，因此被视为面临这些严峻健康问题的患者的一种有希望的治疗选择。

• 质量控制的监管支持

医用大麻生产、分销和质量控制的强大监管框架可以赢得患者和医疗保健提供者的信任，从而促进市场增长。合规性可确保安全性和有效性，这对于在医疗环境中得到广泛接受和使用至关重要。监管明确性可以增强信心，鼓励对不断发展的医用大麻行业的投资和参与。

机会

• 注重以患者为中心的个性化治疗

The patient-centric approach prioritizes personalized treatment plans, prompting healthcare providers to integrate medical cannabis into comprehensive therapeutic strategies. This emphasis on individualized care drives demand for cannabis-based therapies, fuelling growth in the medical cannabis market as it becomes increasingly recognized as a valuable component of patient-centred healthcare.

• Growing Acceptance and Awareness Among Public

Increasing public acceptance and awareness of cannabis's therapeutic benefits for various medical conditions fuel the demand for medical cannabis products. As understanding grows, the desire for alternative treatments, propelling the market forward with heightened interest in its potential health benefits.   

Restraints/Challenges

• Complexities of Intellectual Property and Licensing for New Entrants

Navigating the complexities of intellectual property rights and licensing agreements in the cannabis industry poses a significant challenge. The intricacies involved can deter new entrants, stifle innovation, and hinder market growth, ultimately limiting the development of novel products and solutions within the medical cannabis market in Thailand. 

• Restrictions for International Trade

International trade restrictions on cannabis may hinder Thailand's medical cannabis market by limiting its ability to import advanced products or export locally produced ones. This constraint restricts access to diverse strains, technologies, and global markets, impeding market growth and reducing competitiveness as Thailand may struggle to keep up with international advancements and collaborations. 

This Thailand medical cannabis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Thailand medical cannabis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In March 2022, Aurora Cannabis Inc. acquired Terra Farma Inc., bolstering its Canadian and Europe’s market presence. The integration of Terra Farma's Thrive team into Aurora's portfolio aims to enhance its Canadian recreational offerings, focusing on premium cannabis products such as dried flowers, pre-rolls, vapor products, and concentrates
• In January 2021, Canopy Growth Corporation launched nine retail franchised cannabis outlets across Ontario, aiming to meet rising consumer demands and boost sales. This expansion reflects the company's strategic efforts to capture market opportunities and strengthen its retail footprint
• In November 2020, Aurora Cannabis entered a strategic supply pact with Cantek Holdings, facilitating the distribution of cannabis products in Israel and diversifying its market reach. This collaboration signifies Aurora's commitment to expanding globally and tapping into emerging markets for sustained growth
• In November 2020, EcoGen Biosciences finalized the acquisition of General Processing LLC, a prominent U.S. hemp processing and extraction firm. This strategic move elevates EcoGen's standing in the medical cannabis market and substantially augments its production capabilities, poised for significant growth

Thailand Medical Cannabis Market Scope

The Thailand medical cannabis market is segmented on the basis of product, source, species, derivatives, application, treatment type, route of administration, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Oil
• Dried Medical Cannabis
• Medical Cannabis Capsules
• Vape Pen
• Whole Flower
• Creams and Moisturiser
• Ground Flower
• Patch
• Mask and Serum
• Cleanser
• Others

 Application

• Pain Management
• Anxiety
• Muscle Spasms
• Nausea
• Appetite Loss
• Cancer
• Arthritis
• Alzheimer’s Disease/Migraines
• Epilepsy
• Depression and Sleep Disorders
• Multiple Sclerosis
• Autism
• Mental Health Conditions
• Elevate Mood
• Others

 Derivatives

• Cannabidiol (CBD)
• Tetrahydrocannibinol (THC)/Delta-8-Tetrahydrocannabiol
• Patch
• Cannabigerol (CBG)
• Cannabinol (CBN)
• Others

 Source

• Natural
• Synthetic

 Species

• Sativa
• Hybrid
• Cannabis Indica

 Treatment Type

• Expectorant
• Antiviral
• Analgesic
• Aphrodisiac
• Psychedelic
• Others

Route of Administration

• Oral Solutions and Capsules
• Smoking
• Topicals
• Vaporizers
• Others

 End User

• Homecare Setting
• Hospital
• Rehab Centres
• Pharmaceutical Industry
• Research and Development Centres,
• Others

 Distribution Channel

• B2C
• B2B

Thailand Medical Cannabis Market Regional Analysis/Insights

The Thailand medical cannabis market is analysed and market size insights and trends are provided by country, product, source, species, derivatives, application, treatment type, route of administration, end user and distribution channel as referenced above.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The Thailand medical cannabis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Thailand medical cannabis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Thailand medical cannabis market. The data is available for historic period 2016-2021.

Competitive Landscape and Thailand Medical Cannabis Market Share Analysis

The Thailand medical cannabis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Thailand medical cannabis market.

Some of the major players operating in the Thailand medical cannabis market are:

• Tilray (U.S.)
• Elixinol (Australia)
• Medical Marijuana, Inc. (U.S.)
• Extractas (Australia)
• Peace Naturals Project Inc. (Canada)
• BOL Pharma (Israel)
• PharmaHemp (Slovenia)
• Kiehl’s Since 1851. (U.S.)
• Canopy Growth Corporation (Canada)
• AURORA CANNABIS INC. (Canada)
•  Althea Company Pty Ltd (Australia)
• Cresco Labs (U.S.)
• IDT Australia (Australia)
• MediPharm Labs Inc. (Canada)
• Thai Cannabis Corporation (Thailand)

SKU-64237